Phase 2 Study to Evaluate EI-001 in Non-segmental Vitiligo Patients
Abroad (travel likely)RecruitingPHASE2
Conditions
Non-segmental Vitiligo
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Marvel Clinical Research, Huntington Beach, California, United States
Contact: Study coordinator (Matthew Campos Site Coordinator) · mcampos@marvelclinical.com · 714-375-5970Skin Care Research, LLC, Hollywood, Florida, United States
U Mass Chan Medical School, Worcester, Massachusetts, United States
Apex Clinical Research Center, LLC (Mayfield), Mayfield Heights, Ohio, United States
Contact: Study coordinator (Dr. Garcia Principal Investigator) · research@apexskin.com · 440-940-2739Center for Clinical Studies, Houston, Texas, United States
Contact: Study coordinator (Mario Guerrero Site Coordinator) · mguerrero@ccstexas.com · 713-528-8818Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan